Carl Zeiss Meditec AG (AFX) — Cash Flow-to-Debt Ratio
Carl Zeiss Meditec AG (AFX) has a Cash Flow-to-Debt Ratio of 0.11x as of September 2025, meaning its operating cash flow of €144.16 Million could theoretically repay 0% of its total liabilities (€1.28 Billion) in one year. Explore AFX long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Carl Zeiss Meditec AG Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Carl Zeiss Meditec AG across 12 annual periods. Also explore balance sheet size of Carl Zeiss Meditec AG for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Carl Zeiss Meditec AG (2014–2025)
Year-by-year debt coverage analysis for Carl Zeiss Meditec AG. For market capitalisation and broader financial context, see AFX market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | €209.86 Million | €1.28 Billion | ▼ -11.1% |
| 2024 | 0.19x | €247.32 Million | €1.34 Billion | ▼ -36.6% |
| 2023 | 0.29x | €250.86 Million | €860.02 Million | ▲ +22.9% |
| 2022 | 0.24x | €188.20 Million | €792.73 Million | ▼ -53.0% |
| 2021 | 0.50x | €362.66 Million | €718.59 Million | ▲ +59.1% |
| 2020 | 0.32x | €178.53 Million | €562.73 Million | ▼ -12.6% |
| 2019 | 0.36x | €219.63 Million | €605.17 Million | ▼ -32.6% |
| 2018 | 0.54x | €187.21 Million | €347.42 Million | ▲ +444.6% |
| 2017 | 0.10x | €37.73 Million | €381.37 Million | ▼ -64.9% |
| 2016 | 0.28x | €111.77 Million | €396.57 Million | ▲ +69.8% |
| 2015 | 0.17x | €56.74 Million | €341.84 Million | ▼ -25.1% |
| 2014 | 0.22x | €63.10 Million | €284.88 Million | — |